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ABSTRACT
The TNF locus on chromosome 6p21 encodes a
family of proteins with key roles in the immune
response whose dysregulation leads to severe dis-
ease. Transcriptional regulation is important, with
cell type and stimulus-specific enhancer complexes
involving the proximal TNF promoter. We show how
quantitative chromatin profiling across a 34kb
region spanning the TNF locus has allowed us to
identify a number of novel DNase hypersensitive
sites and characterize more distant regulatory ele-
ments. We demonstrate DNase hypersensitive sites
corresponding to the lymphotoxin alpha (LTA) and
tumour necrosis factor (TNF) promoter regions, a
CpG island in exon 4 of lymphotoxin beta (LTB),
the 3’ end of nuclear factor of kappa light polypep-
tide gene enhancer in B-cells inhibitor-like 1
(NFKBIL1) and 3.4kb upstream of LTA. These sites
co-localize to highly conserved DNA sequences
and show evidence of cell type specificity when lym-
phoblastoid, Jurkat, U937, HeLa and HEK293T cell
lines are analysed using Southern blotting. For
Jurkat T cells, we define histone modifications
across the locus. Peaks of acetylated histone H3
and H4, together with tri-methyl K4 of histone H3,
correspond to hypersensitive sites, notably in exon
4o fLTB. We provide evidence of a functional role
for an intergenic DNase I hypersensitive site distal
to LTA in Jurkat cells based on reporter gene
analysis, with evidence of recruitment of
upstream stimulatory factors (USF) transcription
factors.
INTRODUCTION
The discovery of regulatory elements within DNA sequen-
ces remains a major priority in the post-genomic era (1).
The sensitivity of DNA to digestion by the non-speciﬁc
endonuclease DNase I has been highly informative as
a tool to identify important regulatory sites including
promoters, enhancers, locus control regions, silencers and
insulators (2–4). DNase hypersensitivity results when the
DNA is rendered more susceptible to enzymatic cleavage
through loss or remodelling of one or more nucleosomes,
events characteristically associated with active regulatory
elements. The gold standard for detection of DNase I
hypersensitive sites has been Southern blotting although
a number of alternative approaches have been developed
including cloning and sequencing (5,6), quantitative PCR
(7) and the use of microarray platforms (8–10). For speciﬁc
genomic regions, quantitative chromatin proﬁling using
real time PCR to deﬁne hypersensitive sites is an attractive
approach as it is reported to be highly sensitive and speciﬁc
(7). Despite this, the sensitivity of the approach is yet to be
independently replicated.
We sought to apply quantitative chromatin proﬁling to
the TNF locus on chromosome 6p21 in order to system-
atically map DNase hypersensitive sites across the region.
The locus contains genes encoding members of the TNF
family, a group of proteins with key roles in immunity and
inﬂammation which have been the focus of intensive basic
science and translational research. These include lympho-
toxin alpha (LTA), tumour necrosis factor (TNF) and
lymphotoxin beta (LTB). The regulation of expression of
these genes is critical to mounting an eﬀective and coordi-
nated immune response. Dysregulation can lead directly
to severe disease as illustrated by studies showing the role
of TNF in the pathophysiology of septic shock (11) and
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rheumatoid arthritis (14)—conditions in which biological
therapies using antibodies and other inhibitors of TNF are
dramatically impacting patient care.
A coordinated and speciﬁc level of TNF gene expression
is required to respond to a diverse array of stimuli,
ranging from antigen binding by B and T cells, to
bacterial lipopolysaccharide, viruses, parasites, mitogens
and cytokines. Intensive study of the transcriptional reg-
ulation of TNF has deﬁned cell type and stimulus-speciﬁc
enhancer complexes involving binding by Ets, Elks-1,
ATF-2, c-jun, Egr-1, Sp1 and NFATp transcription fac-
tors to the highly conserved proximal TNF promoter, and
recruitment of co-activator proteins including CREB
binding protein and p300 (15–19). A number of other
regulatory elements have been reported including within
the third intron of TNF (20) and the 30-UTR (21) together
with more distal NFkB elements in the promoter (22,23)
and downstream of TNF (24). The transcriptional regula-
tion of other genes in the TNF locus is much less well
characterized. The proximal LTA promoter is highly con-
served with NFkB playing an important role in LTA indu-
cibility in T cells and HTLV infected cell lines (25,26)
while there is evidence that binding by HMGAIa (27)
and NFAT (28) is important at more distal sites in the
promoter. There is evidence of context speciﬁcity in reg-
ulation of LTA transcription with CD40 and IL4 respon-
sive regions involving NFkB and STAT respectively (29).
For LTB, the highly conserved proximal promoter con-
tains important binding sites for transcriptional regulation
including NFkB and Ets transcription factors, with the
latter playing a stimulus-speciﬁc role (30,31).
It remains unclear whether more distant regulatory ele-
ments such as enhancers, locus control regions, silencers
or insulators play a role in the speciﬁc or coordinated
regulation of this cluster of genes. Polymorphism in the
region has been associated with a range of autoimmune,
inﬂammatory and infectious diseases including myocardial
infarction (32), rheumatoid arthritis (33), cerebral malaria
(34) and leprosy (35). The ﬁne mapping of disease associa-
tions in this region has proved problematic due to the
extent of linkage disequilibrium and diﬃculty of deﬁning
functionally important variants. The resolution of DNase
hypersensitive sites in intergenic or other genomic regions
would facilitate both our understanding of the regulation
of this cluster of genes, and attempts to ﬁne map and
identify regulatory polymorphism. The data relating to
DNase hypersensitivity is limited mainly to the TNF and
LTA promoter regions (20,36–43). In human monocytes,
monocyte-like cell lines and T cell lines, constitutive
DNase hypersensitive sites have been identiﬁed localizing
to the proximal TNF promoter (20,36–40). In Jurkat T
cells, hypersensitive sites were also reported in the third
intron of TNF and 30-UTR, as well as the ﬁrst intron of
LTB; the same pattern was found for the monocytic cell
line THP-1 except the TNF intronic and 30-UTR hyper-
sensitive sites were absent for this cell line (20,40). A
DNase I hypersensitive site in the LTA promoter region
was reported in THP-1 cells and primary human mono-
cytes (38). DNase hypersensitive sites have also been iden-
tiﬁed in porcine peripheral blood mononuclear cells
corresponding to the TNF promoter and third intron,
together with the LTA promoter/50-UTR (41); and in
murine T cells involving the TNF and LTA promoter
regions, as well as sites 5kb upstream of LTA and 3kb
downstream of the TNF transcriptional start site (42).
In this study, we sought to systematically deﬁne and
validate DNase I hypersensitivity across a 34kb region
spanning the TNF locus and ﬂanking sequences. We
were able to successfully establish the approach of quan-
titative chromatin proﬁling in our laboratory, to validate
previously reported DNase hypersensitive sites in the
locus and to demonstrate a number of novel sites that
are candidate locations for regulatory elements. These
sites were conﬁrmed and further resolved by Southern
blotting a panel of human cell lines including Jurkat
T cells, the monocyte-like cell line U937, HeLa and
HEK293T cells. Overall we report six novel DNase hyper-
sensitive sites in the TNF locus which show cell type
speciﬁcity and demonstrate striking co-localization to evo-
lutionarily conserved sequence elements. We complement
this work with chromatin proﬁling for speciﬁc histone
modiﬁcations across the locus in Jurkat T cells, and pro-
vide evidence that one of the DNase hypersensitive sites in
an intergenic region 3.4kb upstream of LTA is associated
with enhancer activity and recruitment of the upstream
stimulatory factors (USF) family of transcription factor
proteins in a human T cell line.
MATERIALS AND METHODS
Cell culture
Human lymphoblastoid cell lines (LCLs), BL41, Jurkat
and U937 cells were grown in RPMI 1640 (Sigma–
Aldrich, Gillingham, Dorset, UK) at 378Ci n5 %C O 2;
HeLa and HEK293T cells were grown in DMEM
(Sigma-Aldrich). Culture media for all lines was supple-
mented with 2mM Glutamine (Sigma), 100U/ml penicillin
(Sigma), 0.1mg/ml streptomycin (Sigma) and 10% FCS
(Sigma). Cells were harvested in mid log phase. Mitogens
used for cell stimulation where indicated were a combina-
tion of 125nM ionomycin (Sigma) and 200nM PMA
(Sigma) (ﬁnal concentration) applied to cells for 6h
unless otherwise stated. The following LCLs were used:
GM12156 obtained from Coriell Institute for Medical
Research (Camden, NJ, USA); PGF, European
Collection of Cell Cultures (Salisbury, Wiltshire, UK);
and QBL (Fred Hutchinson Cancer Research Center
International Histocompatibility Working Group Cell
and Gene Bank, Seattle, WA, USA).
DNase I digestions
We followed the methodology described by Dorschner
et al. (7) with some modiﬁcations. Cells in suspension
were pelleted at 500g, washed twice with cold PBS and
counted using a haemocytometer. Cells were resuspended
in aliquots using 19ml ice-cold buﬀer A (15mM Tris–Cl
pH 8, 15mM NaCl, 60mM KCl, 1mM EDTA pH 8,
0.5mM EGTA pH 8, 0.5mM spermidine, 0.15mM sper-
mine) then 6ml of 0.08% NP-40 in buﬀer A was added
drop-wise to each of the cell aliquots and incubated on ice
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staining. Nuclei were centrifuged at 1000g for 3min at
48C then washed in 20ml fresh buﬀer A before resuspen-
sion in buﬀer A to a concentration of 10
8 nuclei per ml.
Serial dilutions of DNase (Roche, Burgess Hill, West
Sussex, UK) in DNase buﬀer (10mM Tris pH 8, 3mM
CaCl2, 75mM NaCl) were prepared on ice. DNase diges-
tions (20–160U/ml) of 10
7 nuclei per DNase treatment
were performed for 3min at 378C after which an equal
volume of stop buﬀer (50mM Tris–Cl pH 8, 100mM
NaCl, 100mM EDTA pH 8) was added. ‘No DNase’ con-
trols were used with sample incubation both on ice and at
378C as per DNase digestions. Samples were then incu-
bated at 378C for 30min with 6mg RNase A (Roche)
before incubating overnight at 558C with proteinase K
(25mg/ml ﬁnal concentration) and SDS (0.05%). DNA
was puriﬁed by phenol–chloroform extraction and ethanol
precipitation. DNA was further puriﬁed by precipitation
with 2M ammonium acetate pH 5.2 (Sigma) and ethanol,
washed with 70% ethanol and resuspended in 500ml
10mM Tris pH 8. Samples were quantiﬁed using an
ND-1000 spectrophotometer (Nanodrop Technologies,
Wilmington, DE, USA).
Southern blotting
About 15mg DNase-treated or control DNA was digested
using the restriction enzyme Sca I (NEB, Hitchin,
Hertfordshire, UK) overnight at 378C. DNA was precipi-
tated on ice using 2M ammonium acetate pH 5.2 and 2.5
volumes 100% ethanol combined with 1ml glycogen
(Roche). DNA was pelleted by centrifugation in a micro-
fuge at maximum speed at 48C for 10min, washed in ice-
cold 70% ethanol and air-dried before re-suspending in
21ml 10mM Tris pH 8. Samples were quantiﬁed by spec-
trophotometer and equal amounts loaded on a 0.8%
1 TBE agarose gel which was run at 30V overnight.
The agarose gel was soaked for 20min in freshly prepared
denaturation solution (0.4M NaOH, 1.5M NaCl) then
transferred onto Hybond N
+ membrane (GE Healthcare
Life Sciences, Amersham, Buckinghamshire, UK) by
upward capillary transfer. After washing with 5 SSC,
the membrane was UV crosslinked using Stratalinker
2400 (Stratagene/Agilent Technologies, La Jolla CA,
USA). Membranes were pre-hybridized with Church
hybridization buﬀer [10mg/ml BSA, 0.25M phosphate
buﬀer, 5% SDS, 1mM EDTA, 0.25M NaCl and 0.1mg/
ml sonicated herring sperm DNA (Roche)] at 658C for at
least 30min. Probes for Southern blotting were generated
by PCR ampliﬁcation of 50ng genomic DNA using
Platinum Taq polymerase (Invitrogen, Paisley,
Renfrewshire, UK) with initial denaturation at 968C for
1min; then 30 cycles of 948C for 45s, 608C for 30s, 728C
for 45s then 728C for 5min. Primers were used at 0.2mM;
primer sequences are available on request. PCR products
were gel-puriﬁed and 50ng of probe was radiolabelled
with a
32P dCTP using random nonamers and Klenow
following the manufacturer’s instructions for the
Megaprime DNA labelling system (GE Healthcare Life
Sciences). Unincorporated nucleotides were removed
using a ProbeQuant G-50 micro column (GE Healthcare
Life Sciences). The probe was denatured at 958C for 5min,
placed on ice, then added to fresh Church hybridization
buﬀer and incubated with the membrane at 658C over-
night in a hybridization oven. Membranes were then
washed in low stringency wash buﬀer (2 SSC 1% SDS)
followed by stringent wash buﬀer (0.5 SSC 0.1% SDS)
and exposed to an autorad.
MappingDNaseIhypersensitivesitesusingquantitativePCR
We followed the methodology described by Dorschner
et al. (7) for quantitative chromatin proﬁling. Primers
were designed to amplify 250bp amplicons which were
contiguous or minimally overlapping. Primer design
followed the parameters described by Dorschner
et al. (7) using Primer 3 (44) software. These included
an optimal product size of 250bp ( 50); primer Tm
(optimal 608C 2),%GC (50% optimal, range 40–80)
and length (optimal 24, range 19–27); and poly X (max-
imum 4). Primers were scanned for repetitive sequences
using a human mispriming repeat library and veriﬁed for
speciﬁcity using the standalone In-Silico PCR (Jim Kent,
http://genome.ucsc.edu/cgi-bin/hgPcr). Primer sequences
are shown in Supplementary Table S1A. Relative DNase
I sensitivity of untreated and DNase-treated DNA was
measured by real time quantitative PCR. Individual reac-
tions comprised 0.9mM forward and reverse primer, Power
Sybr Green PCR master mix (Applied Biosystems,
Warrington, Cheshire, UK) (containing SYBR Green 1
Dye, AmpliTaq Gold DNA Polymerase LD, dNTPs with
dUTP/dTTP blend, Passive Reference 1 and optimized
buﬀer components), and 20ng template DNA made up
to a 10ml reaction volume with water. The samples and
master mix were pipetted into 384 well reaction plates
robotically using the Matrix Platemate Plus and plates
sealed using a manual heat sealer and Abgene clear seal
strong seals. Reactions were thermocycled on an ABI
7900HT (Applied Biosystems) with each reaction run in
triplicate. To allow normalization of ampliﬁcation eﬃ-
ciency, a dilution series for each sample analysed (40, 20
and 10ng) was included on every individual 384 well plate
with a primer pair amplifying a reference amplicon within
aninactive and DNase-insensitive RHO (Rhodopsin) locus
(3q21–q24) (7). Melt curve data for each primer pair used
were recorded.
Analysisof quantitative PCR data
Data from primer pairs showing multiple peaks upon
melting curve analysis were excluded from further analysis
on the basis of potentially having multiple products. For
each of four replicate DNase samples, at each primer a
robust average of the triplicate raw values was generated,
excluding any value >1 SD from the mean. In total, 20
primers were excluded on the basis of melting curve anal-
ysis and <0.5% of raw values were >1 SD from the raw
mean. The ampliﬁcation eﬃciency of test primers was nor-
malized to that of the DNase-insensitive RHO locus
primers. Using the RHO dilution series, present on
each plate, a reference ampliﬁcation curve was gener-
ated and ampliﬁcation eﬃciency (E) was calculated as
E ¼ 10 1=slope (45). The ampliﬁcation eﬃciency of all test
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reference eﬃciency. A relative copy number ratio was
generated using the 2 Ct equation (46), computed as
2
 [(T   R)D   (T   R)U] where T is the test primer value, R
is the RHO reference primer and D and U represent the
DNase-treated and untreated samples, respectively.
Statistical analysis of relative copy number ratios closely
followed that of Dorschner et al. (7), where a baseline
of DNase I sensitivity measurements across the region is
calculated as a lowess-smoothed robust mean. The robust
mean was calculated as a 20% trimmed mean and
symmetric lowess smoothing was performed with a span
of 0.2. Outliers were identiﬁed and the remaining data
centred around the baseline. Signal-to-noise ratios (SNR)
were computed as described in Dorschner et al. (7) where
the SNR for each amplicon is the absolute deviation of it’s
trimmed mean from the baseline, divided by the median
average deviation of the centred baseline. To identify puta-
tive DHS sites, locations were identiﬁed whose trimmed
mean lay outside the lower 90% conﬁdence limit of the
baseline and whose SNR exceeded a threshold of 2.
RNA extraction, cDNA synthesis andquantitative PCR
Total RNA was prepared using the RNeasy Mini kit
(Qiagen, Crawley, West Sussex, UK) following the manu-
facturer’s instructions with inclusion of a DNase I diges-
tion step on the RNeasy minicolumn. Following
quantiﬁcation, cDNA was prepared using SuperScript
III (Invitrogen) using random primers and following the
manufacturer’s instructions which included digestion with
RNase H (Invitrogen) following cDNA synthesis. Control
RT reactions omitting the reverse transcriptase were
included for each sample. Quantitative PCR was per-
formed using SYBR Green Supermix (BioRad, Hemel
Hempstead, Hertfordshire, UK) on an iQ Cycler
(BioRad). PCR eﬃciency was determined and melt-curve
analysis performed for gene-speciﬁc primer sets (sequences
listed in Supplementary Table S1B). Relative gene tran-
script levels were determined by the Ct method.
Chromatin immunoprecipitation
About 100 10
6 cells in mid log phase were subjected to
formaldehyde cross-linking (1% ﬁnal concentration) for
15min at room temperature, quenched by addition of gly-
cine (0.125M ﬁnal concentration). Cells were lysed and
nuclei isolated as described (47) with sonication in the
presence of 212–300 micron glass beads (Sigma) using a
Branson 450 Soniﬁer with a constant power amplitude of
40% for six pulses of 30s on ice, cooling on ice for 1min
between pulses. Sonicated material was adjusted to 0.5%
Sarkosyl and gently mixed for 10min at room temperature
before centrifugation at 10000g at 48C for 10min to
remove cell debris. Immunoprecipitation was performed
using sheep anti-rabbit IgG coated Dynabeads
(Invitrogen) pre-incubated with speciﬁc primary antibo-
dies (histone H3 tri-methyl K4 rabbit ab 8580-50)
(Abcam, Cambridge, Cambridgeshire, UK), anti-
diacetylated histone H3 06-599 (Upstate/Millipore,
Watford, Hertfordshire, UK), anti-tetracetylated histone
H4 #06-866 (Upstate), anti-USF1 sc229 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), anti-USF2 sc862
(Santa Cruz) and anti-actin #A-2066 (Sigma) in PBS with
5mg/ml BSA. For histone IPs, chromatin was incubated
with antibody-coated beads in 10mM Tris pH 8, 1mM
EDTA, and 1% Triton X-100, 0.1% sodium deoxycho-
late, and 5mg/ml pepstatin at 48C overnight in a rotating
platform. Beads were washed eight times in RIPA buﬀer
(10mM Tris pH 8, 1mM EDTA, 1% NP-40, 0.7%
sodium deoxycholate, 0.5M LiCl) with 2-min incubation
on ice between washes. For USF IPs, the IP buﬀer used
was 17.5mM Tris–HCl pH 8, 1.4mM EDTA, 0.55%
Triton X-100, 0.01% SDS, 16.7mM NaCl; IPs were
washed twice in a low-salt wash buﬀer (20mM Tris HCl
pH 8, 2mM EDTA, 1% Triton X-100, 0.1% SDS,
150mM NaCl), then twice in high-salt wash buﬀer
(same as low salt wash buﬀer but containing 500mM
NaCl) and then twice in LiCl wash buﬀer (10mM Tris
HCl pH 8, 1mM EDTA, 1% NP-40, 1% DOC, 250mM
LiCl), rotating for 5min between each wash. 1  complete
protease inhibitor cocktail (Roche) was used in all IP and
wash buﬀers. Samples were washed once with TE and
eluted in TE containing 1% SDS. Samples were vortexed
brieﬂy to resuspend the beads and incubated at 658C for
10min, centrifuged for 30s at maximum speed and super-
natant transferred to a new tube. Cross-links were
reversed at 658C overnight then digested with proteinase
K for 2h at 378C. DNA fragments were puriﬁed by
phenol–chloroform extraction and precipitated using
3M NaAc (pH 5.2) in the presence of glycogen. DNA
was treated with 0.5mg RNase A and following spin
column puriﬁcation was eluted in 10mM Tris pH 8. For
quantitative chromatin immunoprecipitation analysis by
real time PCR we followed the methodology described
by De Gobbi and colleagues (48). Primer sets used for
DHS proﬁling were used to amplify 250bp amplicons at
 1kb intervals across the TNF locus with the amount of
DNA immunoprecipitated by a speciﬁc histone antibody
quantiﬁed relative to that of non-immunoprecipitated
(input) DNA and normalized relative to a control
sequence in the 18S ribosomal RNA gene.
Reporter gene assays
The DNA fragment corresponding to the human LTA
promoter and 50 UTR (chr 6:31647635–31648498) was
generated by PCR ampliﬁcation of genomic DNA from
the PGF cell line which provides the reference sequence of
the human genome and is homozygous over the MHC
(49). PCR products were cloned into BglII/NcoI sites
upstream of the ﬁreﬂy luciferase gene in the pGL3-Basic
vector (Promega, Southampton, Hampshire, UK). Using
the same approach the DHS 44500 conserved region
(313bp) (31644374–31644686) was cloned into BamHI/
SalI sites downstream of the luciferase gene. Alternative
constructs were prepared also using the BamHI/SalI sites,
inserting the conserved region in reverse orientation, or
the ﬂanking region telomeric (ﬂank1, 319bp) (31644049–
31644367) or centromeric (ﬂank2, 316bp) (31644697–
31645012) of DHS 44500. All constructs were veriﬁed by
DNA sequencing. Jurkat cells were transiently transfected
using Lipofectamine LTX and PLUS reagent (Invitrogen)
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recover after transfection for 1h, then where indicated
were stimulated with 125nM ionomycin and 200nM
PMA. Cells were harvested after 24h and luciferase
assays performed following the manufacturer’s protocol.
Fireﬂy luciferase constructs were co-transfected with pRL-
TK (Promega) encoding Renilla luciferase to allow nor-
malization of transfection eﬃciencies. Two independent
endotoxin-free preparations of all constructs were ana-
lysed in transfection experiments.
Solid phase DNaseI footprinting
This was performed as previously described (50,51).
Forward and reverse radiolabelled DNA probes spanning
DHS 44500 (31644349–690 and 31644347–686, respec-
tively) were generated by PCR using PGF genomic DNA
as template with one biotinylated primer and one primer
end labelled with g32P using T4 polynucleotide kinase
(primer sequences given in Supplementary Table S1C).
Binding reactions comprised radiolabelled DNA probe
adsorbed onto magnetic Dynabeads M-280 Streptavidin
(Invitrogen) in binding reaction buﬀer either alone
(naked DNA) or incubated with crude nuclear extract
(NE) prepared from Jurkat cells. DNA-binding reactions
were subjected to DNase I digestion (0.0075 0.25U) for
30s, washed and analysed on a 7% acrylamide urea gel
(7M). Areas of protection were localized with a Maxam–
Gilbert sequencing ladder.
NEs, electrophoretic mobility shiftassays
Nuclear extracts were prepared from Jurkat T cells as
previously described (52). Oligonucleotide probes for the
following sites were radiolabelled: ‘USF DHS 44500’
spanning the putative USF binding site in DHS 44500
(For: agctCACATGCACGTGACACTGAG, Rev: agctC
TCAGTGTCACGTGCATGTG); ‘USF MLP’ spanning
the USF binding site from the adenovirus major late pro-
moter (For: agctGTAGGCCACGTGACCGGGT, Rev:
agctACCCGGTCACGTGGCCTAC); ‘EGR’ spanning
an EGR binding site (For: agctAAATCCCCGCCCCC
GCGATGGA, Rev: agctTCCATCGCGGGGGCGGG
GATTT). Electrophoretic mobility shift assays (EMSA)
were performed as previously described (23); for supershift
analysis, antibodies to USF1 (sc229), USF2 (sc862) and
Oct1 (sc232) were used (Santa Cruz).
Resequencing
A total of 92 chromosomes were resequenced over the
region 31644170–31644820 for unrelated individuals from
each of the Caucasian (CEU) and African (YRI) cohorts of
the International HapMap Project with 2  coverage using
two amplicons (Agencourt Bioscience, Beverly MA, USA).
One CEU sample failed quality control for one amplicon.
Identiﬁers of speciﬁc individuals resequenced are available
on request. All coordinates in the paper are from NCBI
build 35.
RESULTS
DNasehypersensitive site mapping ofthe TNF locus
andflanking regionsby quantitative chromatin profiling
We aimed to deﬁne putative regulatory regions in the TNF
locus and ﬂanking genomic regions. DNase hypersensitiv-
ity assays to map sites of chromatin accessibility asso-
ciated with transcriptionally active chromatin have been
a powerful method of deﬁning regulatory elements. This is
particularly useful to screen intergenic regions which may
contain enhancer and other regulatory elements acting at
a distance from a gene. We ﬁrst validated the approach of
quantitative chromatin proﬁling using tiled PCR ampli-
cons (7) for a known DNase hypersensitive site in the
a-globin complex on chromosome 16p13.1 (53) using a
lymphoblastoid B cell line GM12156 (Supplementary
Figure S1A and B). We then proceeded to map DNase
hypersensitive sites across the TNF locus by analysing a
34kb genomic region centromeric to nuclear factor of
kappa light polypeptide gene enhancer in B-cells
inhibitor-like 1 (NFKBIL1), which included LTA, TNF,
LTB, leukocyte speciﬁc transcript 1 (LST1) and natural
cytotoxicity triggering receptor 3 (NCR3) genes using
GM12156 (Figure 1). DNase hypersensitive sites were
found in the LTA and TNF promoter and 50-UTR,
denoted ‘DHS 48000’ and ‘DHS 51250’, which localized
within 0.1kb of the transcriptional start sites of the two
genes, respectively. Both hypersensitive sites were present
in unstimulated and stimulated cells, being more pro-
nounced and extensive (involving two rather than one
PCR amplicons) in chromatin from stimulated cells.
Two DNase hypersensitive sites were observed 30 to
NFKBIL1: ‘DHS 35000’ was found 0.3kb downstream of
exon 4 of NFKBIL1 and observed only in unstimulated
cells; ‘DHS 36000’ was 1.6kb 30 to NFKBIL1 and present
in chromatin from both unstimulated and stimulated cells.
In the intergenic region between NFKBIL1 and LTA,
a DNase hypersensitive site (denoted ‘DHS 44500’) was
found 3.4kb upstream of LTA. This was present in unsti-
mulated and stimulated cells. A hypersensitive site
(denoted ‘DHS 56700’) was also observed at the 30 end of
LTB, localizing to exon 4, and lying within the only sig-
niﬁcant CpG island in this 34kb region. In unstimulated
cells, a further ﬁve regions showed SNRs supporting the
presence of a hypersensitive site, however the 90% conﬁ-
dence threshold of DNase I sensitivity ratios in these cases
was not met in all but two instances. Interestingly, four of
these sites displayed similar marginal evidence in the sti-
mulated cells where an additional site was also suggested
with evidence very near to thresholds (‘DHS 38000’).
Identification of DNasehypersensitive sites by Southern
blotting
The DNase hypersensitive sites DHS 48000 and DHS
51250 near the LTA and TNF transcriptional start sites
are consistent with the well-documented importance of
these regions in transcriptional initiation of these genes,
and hypersensitive sites have been previously reported in
the proximal TNF and LTA promoter regions (20,36–39).
Our quantitative chromatin proﬁling data also identiﬁed
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intergenic regions as well as the only CpG island in the
TNF locus in exon 4 of LTB. We proceeded to try to
conﬁrm the presence of these hypersensitive sites by con-
ventional Southern blotting of Sca I restriction fragments
spanning a 28.4kb region from NFKBIL1 to LTB which
encompassed the hypersensitive sites deﬁned by quantita-
tive chromatin proﬁling.
Context speciﬁcity has been a hallmark of many studies
analysing the transcriptional regulation of TNF and LTA,
and we therefore also sought to determine whether these
sites of DNase hypersensitivity were cell type speciﬁc.
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Figure 1. Quantitative chromatin proﬁling for a 34kb region spanning the TNF locus and ﬂanking genes in GM12156. This was carried out for four
replicate DNase I digestions to give DNase I sensitivity measurements (ratios of copy number in treated compared to untreated samples) from 140
contiguous PCR amplicons designed to tile across the region (31634558–31668876). All samples were quantiﬁed in triplicate by Q-PCR. Relative
DNase I sensitivity measurements are shown (DNase I-treated versus untreated) together with SNRs with genomic coordinates given along the
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stimulated cells (31651222–31651465) which was also present in unstimulated cells but to a lesser extent; ‘DHS 56700’ in exon 4 of LTB in
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are suggested with marginal evidence (shown highlighted in grey on ﬁgure).
4850 Nucleic Acids Research, 2008, Vol. 36, No. 15Chromatin was analysed from a panel of diverse human
cell lines commonly used in gene expression studies includ-
ing the Jurkat T cell leukaemia cell line; the U937 his-
tiocytic lymphoma cell line which displays monocytic
characteristics; the cervical epithelial carcinoma cell line
HeLa; and the embryonic kidney cell line HEK293T.
Quantitative real time PCR assays of relative transcript
abundance were carried out to assess how expression
of the genes of interest within the TNF locus varied
between cell lines. All the cell types, including GM12156,
showed inducible expression of LTA and TNF after 6h of
stimulation with a combination of PMA and ionomycin
(Figure 2). Expression of LTB was highly inducible
in Jurkat cells. However the levels of expression varied
between cell types, being highest for LTA in the LCL
and Jurkat cell lines, for TNF in the LCL and U937 cells,
and for LTB in Jurkat cells (Supplementary Figure S2).
The most marked DNase sensitivity seen on quantita-
tive chromatin proﬁling of GM12156 was at DHS 44500, a
hypersensitive site within an intergenic region located
3.4kb 50 to LTA which has very recently been reported
to be of regulatory signiﬁcance in murine T cells (denoted
HSS-9) (42). We analysed independent chromatin pre-
parations from the same cell line by Southern blotting a
10.4kb restriction fragment that spanned the region of
interest 50 to LTA. In the presence of higher concentra-
tions of DNase, a clear faster migrating labelled band
4.8kb in size was detected, demonstrating a DNase hyper-
sensitive site at the position of DHS 44500 revealed by
quantitative chromatin proﬁling (Figure 3A). This hyper-
sensitive site is present constitutively and after induction
with mitogen. A number of much smaller bands were also
detected migrating at 1.4, 1.2 and 0.95kb which localize to
the LTA promoter and 50-UTR (within 0.1kb of the LTA
transcriptional start site, and 0.2kb and 0.4kb down-
stream respectively) and reﬁne the DNase hypersensitivity
corresponding to DHS 48000 found on quantitative chro-
matin proﬁling. In mitogen stimulated cells, a weak 2.9kb
band was also observed, denoted DHS 46500, and located
at 1.5kb 50 to LTA. This site was of borderline signiﬁcance
on earlier quantitative chromatin proﬁling but was
subsequently found to be present in other B cell lines
(Figure 3A) and to co-localize with a conserved region
of DNA (see following section). We investigated whether
the DHS 44500 hypersensitive site was present in a second
EBV immortalized cell line, QBL. Southern blotting
demonstrated the presence of the site in chromatin from
both induced and uninduced cells (Figure 3A). We then
investigated whether this site was restricted to EBV
immortalized LCLs. In the non-EBV transformed B cell
line BL41, we found that the hypersensitive site was also
present constitutively. We found the same hypersensitive
site in a T cell line (Jurkat) and the human monocyte-like
cell line U937, however the site was not observed in HeLa
cells or HEK293T cells (Figure 3A).
We investigated whether the novel DNase hypersen-
sitive sites 30 to NFKBIL1 found on quantitative chroma-
tin proﬁling were present in GM12156 and other cell
types (Figure 3B). Southern blotting a 6.9kb restriction
digest spanning the region resolved the hypersensitive site
DHS 36000, noted on quantitative chromatin proﬁling, to
a higher ﬁdelity with two bands present of 3 and 2.7kb
corresponding to 1.3 and 1.6kb 30 to exon 4 of NFKBIL1.
A number of weaker bands were also present in the LCLs
which were more clearly demonstrated in the Jurkat and
U937 cell lines as DNase hypersensitive sites, namely DHS
35000 seen as a discrete 4kb band on Southern blotting
corresponding to a region 0.3kb 30 to exon 4 of NFKBIL1;
while 2.2 and 1.4kb bands were also present (DHS 36800
and DHS 38000). No eﬀect of cell stimulation with mito-
gen was observed. None of these sites were consistently
demonstrated on Southern blots of DNase I digested chro-
matin from HeLa or HEK293T cell lines.
The DNase hypersensitive site DHS 51250 in the TNF
promoter region identiﬁed on quantitative chromatin pro-
ﬁling in GM12156 was conﬁrmed by Southern blotting
(Figure 3C). A 5kb fragment was observed in addition to
the 6.83kb full length Sca I digest in GM12156, U937 and
HeLa cell lines but not Jurkat or HEK293T cells. In Jurkat
and GM12156 cells, a faster migrating 3.5kb fragment was
observed localizing to intron 3 of TNF and denoted DHS
52750. Two DNase hypersensitive sites were found to be
present constitutively in and around the LTB gene. DHS
56700, present within exon 4 of LTB on quantitative chro-
matin proﬁling, was clearly demonstrated on Southern
blotting DNase digested chromatin from a range of cell
types (Figure 3D). These included GM12156, Jurkat,
U937 and HEK293T cells. Interestingly this DNase hyper-
sensitive site was absent in HeLa cells where a 2.3kb frag-
ment (DHS 58200) was observed localizing within 0.1kb 50
toexon1ofLTB.TheresultsofourDNaseIhypersensitive
site mapping experiments across the TNF locus are sum-
marized in Figure 4.
Sequenceconservation and phylogeneticfootprinting
DNA sequence of regulatory signiﬁcance is typically sub-
ject to evolutionary selective pressure leading to DNA
sequence conservation when genomic sequences from dif-
ferent species are compared (54). We proceeded to analyse
the 34kb region to identify sequence conservation and evi-
dence of selection producing phylogenetic footprints.
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Figure 2. Inducibility of genes in the TNF locus by mitogen stimula-
tion. Inducibility of NFKBIL1, LTA, TNF and LTB is shown as the
ratio of transcript abundance in unstimulated cells versus cells induced
with a combination of PMA and ionomycin for 6h. Transcript levels
were assayed using gene-speciﬁc primers normalized to an ACTB con-
trol primer set by real time Q-PCR using the Ct method.
Mean SD of three replicates are shown.
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Nucleic Acids Research, 2008, Vol. 36, No. 15 4853We used a conservative threshold to deﬁne conserved
regions with a lod score of  99 by analysis of PhastCons
Conserved Elements (17-way Vertebrate Multiz
Alignment) (55) on the UCSC Genome Browser
Database. This revealed 11 regions, which included
exonic sequences and known promoter regions together
with a number of intergenic regions. Strikingly, 6 out of
the 11 highly conserved regions aligned exactly to the
DNase hypersensitive sites we mapped by quantitative
chromatin proﬁling and Southern blotting (Figure 4).
Analysis for PhastCons Conserved Elements (17-way
Vertebrate Multiz Alignment) (55) on the UCSC Genome.
One of these highly conserved regions (score 438, lod 99)
spanned a 118bp region (from 31644420 to 31644538)
within DNase hypersensitive site DHS 44500 located
3.4kB 5’ to LTA. This was associated with a peak (between
31644420 and 31644700) in predicted regulatory potential
based on comparison of seven species analysed by
ESPERR (Evolutionary and Sequence Pattern Extraction
through Reduced Representations) with a maximum score
of 0.36 (mean 0.2, variance 0.009), a score above 0.01 indi-
cating a very marked resemblance to alignment patterns
typical of regulatory elements in the training set used
(56). Very high sequence conservation was observed over
the DNase hypersensitive sites found at the LTA and TNF
promoter regions, DHS 48000 (score 510, lod 187) and
DHS 51250 (score 494, lod 163) respectively. DHS 56700
was noted to align with a CpG island within LTB and show
strong sequence conservation (score 449, lod 109).
Similarly high levels of conservation were noted for DHS
35000 (score 471, lod 132) and DHS 36000 (score 529, lod
222) 30 to NFKBIL1.
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Figure 4. Sequence conservation analysis and DNase I hypersensitivity map of TNF locus. Data from quantitative chromatin proﬁling and southern
blotting for GM121565, Jurkat, U937, HeLa and HEK293T cells is summarized in the context of genomic structure and DNA sequence conservation
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We proceeded to analyse histone modiﬁcations over a
25.4kb region spanning the TNF locus from NFKBIL1
to LTB. Jurkat T cells were chosen for this analysis as a
representative cell type in which the majority of DNase
hypersensitive sites were found and all the genes
expressed, with signiﬁcant inducibility for LTA, TNF
and LTB. We performed chromatin immunoprecipitation
experiments using speciﬁc histone antibodies to identify
modiﬁcations associated with active chromatin (57).
Quantitative real time PCR was used to map relative
enrichment of chromatin modiﬁcations across the region
at 1kb intervals (Figure 5). Histone modiﬁcations were
assessed across a time course following mitogen stimula-
tion with peak levels of enrichment relative to input con-
trols seen at 2h after induction. We found a striking peak
of histone acetylation (H3 and H4) at exon 4 of LTB
which was associated with a peak in tri-methylated
lysine 4 of histone H3. Elsewhere across the locus,
peaks of histone acetylation and tri-methylation were
found at the 30 end of NFKBIL1, and the TNF and LTA
promoter regions. Enrichment of tri-methylated lysine 4
was also found corresponding to the conserved DHS
44500 in the intergenic region 3.4kb upstream of LTA;
this was also associated with inducible acetylation of his-
tone H3 and H4 (Figure 5).
Functional characterization of DHS445005’ to LTA
We proceeded to characterize further the regulatory sig-
niﬁcance of DHS 44500, a DNase hypersensitive site in the
intergenic region upstream of LTA which showed
sequence conservation and was associated with a peak of
inducible histone modiﬁcations in Jurkat cells. We inves-
tigated ﬁrst whether the segment of DNA spanning this
site showed evidence of enhancer activity. We engineered a
pGL3 LTA promoter construct in which the proximal
LTA promoter region and 50-UTR was placed imme-
diately upstream of the luciferase reporter gene: the
former encompasses the conserved proximal LTA pro-
moter region previously reported as showing maximal
activity on reporter gene assays (58,59). Transient trans-
fection assays of Jurkat cells showed 3-fold induction
of gene expression of this LTA promoter construct on
stimulation of transfected cells with PMA and ionomycin.
When in addition the 313bp conserved region spanning
DHS 44500 was inserted downstream of the luciferase
gene, we found signiﬁcant diﬀerences in level of expression
following mitogen stimulation (Figure 6). This was depen-
dent on the orientation of the DNA segment corres-
ponding to DHS 44500, with induction after stimulation
increased to 9.2-fold (P=0.01 on paired t-testing versus
pGL3 construct containing only the LTA promoter,
two-tailed). In contrast, we found no diﬀerence in levels
of gene expression when the ﬂanking regions were inserted
downstream of the luciferase gene.
We then performed DNase I footprinting experiments
in order to deﬁne the nature and extent of transcription
factor binding over a 343bp region spanning DHS 44500.
Using NEs from both unstimulated and mitogen-induced
Jurkat T cells, we observed a strong region of protection
at 31644570–582, with ﬂanking hypersensitivity to diges-
tion, using probes radiolabelled on either the forward or
reverse strands (Figure 7). This footprinted region spans a
core E-box motif (CANNTG) with the sequence
CACGTGAC reported to be bound with high aﬃnity by
members of the USF transcription factor family, in partic-
ular USF-1 (60). We further investigated recruitment of
USF transcription factors at DHS 44500 using EMSA and
chromatin immunoprecipitation experiments (Figure 8).
Two major complexes (denoted I and II) were observed
on EMSA using a radiolabelled oligoduplex probe corre-
sponding to the region of protection seen on DNase I
footprinting; these co-migrated with complexes seen with
a probe matching a classical USF binding site from the
adenovirus major late promoter (61). The complexes were
found to be speciﬁc on competition assays, being eﬀec-
tively competed away by unlabelled self or the classical
binding site but not by an unrelated probe. Supershift
assays demonstrated complex I was a USF1 homodimer,
and complex II a heterodimer of USF1/USF2. Chromatin
immunoprecipitation experiments using the same cell
line demonstrated that USF1 and USF2 were constitu-
tively recruited in vivo (Figure 8). The mouse sequence
corresponding to the human USF binding site in DHS
44500 shows a single nucleotide diﬀerence (CCCG
TGAC versus CACGTGAC) but showed comparable
in vitro binding of USF1/USF2 on EMSA (Supplementary
Figure S3A). Our DNase I footprinting experiments
also showed evidence of weak regions of protection in
two other regions, 31644514–525 and 31644450–462
(Figure 7). The sequence within the latter (GGGAAAG
TCC) corresponds to the consensus binding site for mem-
bers of the Rel/NF-kB family of transcription factors p50/
p65 (GGGRNYYYCC) (62,63) as well as members of the
nuclear factor of activated T cells (NFAT) transcription
factor family (64). EMSA experiments demonstrated bind-
ing of p50/p65 and p50/p50 to this region of DHS 44500
(Supplementary Figure S3B). Based on supershift experi-
ments there may be other speciﬁc proteins recruited to
both this site and the USF binding site. A speciﬁc complex
was also observed binding to an oligonucleotide probe
corresponding to the region 31644514–525 on EMSA;
the speciﬁc DNA binding proteins involved remain to be
identiﬁed (Supplementary Figure S3C).
Finally, we sought to determine the extent of nucleotide
diversity over a 650bp region spanning DHS 44500
(31644170–031644820). A total of 92 chromosomes were
resequenced for unrelated individuals from each of the
CEU and YRI cohorts of the International HapMap
Project (Supplementary Figure S4A–C). This analysis
revealed two common SNPs were located near DHS
44500 but outside the conserved region, rs2844483 and
rs2844484, of which rs2844484 had been previously vali-
dated but was of unknown allele frequency in dbSNP.
We found the SNPs were in signiﬁcant linkage disequili-
brium with minor allele frequencies of 0.378 and 0.370
in the CEU population, and 0.25 and 0.261 in the YRI
population respectively. These SNPs form part of an 8kb
haplotypic block extending into the 30 region of NFKBIL1
which includes DHS 36000. In addition a novel SNP
(ss99307025) was identiﬁed on one chromosome
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4856 Nucleic Acids Research, 2008, Vol. 36, No. 15(GM12155) at 31644594 in the CEU but not YRI
population.
DISCUSSION
We have presented data providing a comprehensive and
systematic analysis of DNase hypersensitivity across the
TNF locus. This genomic region encompasses a cluster of
genes of critical importance in the immune response whose
regulation remains incompletely understood. Our analysis
of chromatin accessibility should facilitate further eﬀorts
to understand the transcriptional regulation of the locus
and has highlighted a number of novel regions of potential
functional signiﬁcance. Our data demonstrates the suc-
cessful application of quantitative chromatin proﬁling to
interrogate a genomic locus spanning 34kb. Quantitative
chromatin proﬁling oﬀers an attractive approach to allow
screening of speciﬁc genomic regions with high speciﬁcity
and sensitivity (7). Our data represents the ﬁrst report to
our knowledge of the successful application of this tech-
nique outside of the laboratory where it was developed
and used as part of the ENCODE project (1). The
approach remains relatively costly due to the number of
real time PCR reactions required but our data shows that
the number of replicate digestions can be reduced while
maintaining high sensitivity due to the low variance and
high SNR observed at hypersensitive sites. We made
extensive use of Southern blotting analysis in this study
to screen diﬀerent cell types for DNase I hypersensitive
sites: this proved to have higher resolution than quantita-
tive chromatin proﬁling and was highly reproducible.
Although more labour intensive, Southern blotting
remains the gold standard in detection of hypersensitive
sites and has previously been used for screening large
genomic regions (65,66).
The TNF locus has been of signiﬁcant research interest
in terms of gene regulation with most work relating to
transcriptional regulation of TNF. We conﬁrmed the pre-
viously reported DNase hypersensitivity in the region of
the human TNF promoter (20,36–39) and within intron 3
in Jurkat T cells (20). Cell type speciﬁcity was found for the
hypersensitive sites we describe within the TNF locus, con-
sistent with previous reports of speciﬁc regulatory mechan-
isms operating dependent on the stimulus and cell type
(67). We have shown here that there are a number of
novel hypersensitive sites in or near ﬂanking genes of puta-
tive regulatory signiﬁcance. Strikingly, the sites found 30 to
NFKBIL1, in an intergenic region between NKFBIL1 and
LTA, and within exon 4 of LTB, co-localize to highly
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Figure 6. Eﬀects of sequences spanning or ﬂanking DHS 44500 on reporter gene expression in Jurkat T cells. Jurkat cells were transiently transfected
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conservation and phylogenetic footprinting concurs with
previous reported analyses of human–mouse conservation
which include this locus and we were able to deﬁne a
number of novel conserved regions (42,68,69).
The transcriptional regulation of NFKBIL1 (also
referred to as IKBL) is currently unknown. The encoded
protein is thought to be a member of the I kappa B family
as it contains ankyrin repeats which allow for interaction
and regulation of NFkB/Rel proteins and, together with
a bipartite protein targeting motif, determine localization
to nuclear speckles (70,71). DNA sequence polymorphism
50 to NFKBIL1 has been associated with susceptibility to
rheumatoid arthritis (72) while resequencing of ancestral
MHC haplotypes identiﬁed a 30 untranslated region
nucleotide substitution on the HLA B44 haplotype, an
extended haplotype associated with susceptibility to auto-
immune disease and cancer (73). Further characterization
of the 30 DNase I hypersensitive sites we have reported
here is likely to be highly informative in terms of the
regulation of NFKBIL1 and resolution of functional poly-
morphisms responsible for haplotypic associations with
this locus. The haplotypic analysis presented here high-
lights how SNPs ﬂanking DHS 44500 may be of potential
relevance to such studies given the 8kb haplotypic block
extending into the 30 region of NFKBIL1 which includes
rs2844483 and rs2844484.
The novel DNase I site in exon 4 of LTB (DHS 56700)
present across a range of cell types may be of particular
signiﬁcance given its co-localization to highly conserved
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4858 Nucleic Acids Research, 2008, Vol. 36, No. 15sequence elements and the only CpG island in the region.
Striking levels of histone H3 and H4 acetylation, together
with tri-methylated lysine 4 of histone H3 were found at
this site in Jurkat T cells. To date, functional analysis of
LTB has been restricted to the proximal promoter region
where Ets and NFkB binding sites have been shown to be
important in PMA inducibility in Jurkat T cells (30,31).
We did not ﬁnd evidence of DNase hypersensitivity in the
promoter region in Jurkat cells or a number of other cell
types except HeLa, which may indicate cell context speci-
ﬁcity in the regulation of LTB and highlights the need for
further research into its regulation which includes regions
outside of the classical promoter.
For the distal hypersensitive site (DHS 44500) localizing
3.4kb upstream of LTA, we have presented data showing
the DNase hypersensitivity is cell type speciﬁc, being pre-
sent only in cell lines of haematological lineage, and is
localized within a region showing chromatin modiﬁcations
associated with transcriptionally active euchromatin in
Jurkat T cells. Using the same cell line, we found that the
region has enhancer activity in a reporter gene assay with
evidence of recruitment of the USF family of basic
helix-loop-helix leucine zipper transcription factors. This
family of transcription factors are involved in regulation
ofmanygenesinvolvedinthestressandimmuneresponses,
acting to modulate transcriptional activation, interact with
coactivators and the pre-initiation complex, and recruit
chromatin remodelling enzymes (60). A DNase hypersen-
sitive site corresponding to DHS 44500 was reported in
murine T cells during revision of this manuscript denoted
HSS-9 (42). This study demonstrated a functional role for
the region involving modulation of expression of TNF via
an intrachromosomal looping mechanism (42). Further
work is required to assess whether a similar mechanism
may be operating in human T cells but our reporter gene
data suggest the human sequence spanning DHS 44500 has
the potential to modulate expression of LTA: this may be
orientation-dependent and show human–murine diﬀer-
ences. Our ﬁndings that DHS 44500 contained a binding
site capable of binding p50 and p65 are consistent with
published analysis of the murine sequence conserved at
this site (denoted NFAT-8,394 in HSS-9) where both
NFATp and p50/p65 were reported to bind in vitro; bind-
ing by NFATp was also demonstrated by ChIP assays in
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Nucleic Acids Research, 2008, Vol. 36, No. 15 4859murine T cells (42). There is also some evidence that DHS
44500 may be present in porcine peripheral blood mono-
nuclear cells as a site was noted approximately 4.4kb
upstream of LTA which lay outside the cloned TNF locus
and was not analysed (41). We identiﬁed two common
SNPs ﬂanking DHS 44500 present in both Caucasian and
African populations; their functional signiﬁcance in terms
of gene expression remains to be determined.
The detailed map of DNase I hypersensitive sites we
have presented here should facilitate our understanding
of potentially distant regulatory elements controlling tran-
scription of this important cluster of genes, and of the
consequences of genetic diversity within such regions for
gene expression.
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